Compared to patients with ER– BC, serum Kyn and IDO1 levels were markedly reduced in patients with ER + BC, and ER messenger ribonucleic acid (mRNA) levels were inversely correlated with the expression of IDO1. This evidence concerns the gene IDO1 and breast cancer.